LLY filling the GAPLooking for this to drop just a little more to fill the gap mid 140's is a buying opportunity
LLY trade ideas
FDA approves additional doses of Trulicity® (dulaglutide) for thLLY: Eli Lilly and Company
2020-09-03 17:12:00
FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes
daily analysis of ELI LILLY AND COMPANYHi friends
the daily chart of this market shows with a high probability a downtrend in the coming days but at the same time it is better to be vigilant of the change of direction towards the opposite please subscribe to receive more analysis
$LLY falling wedge$LLY is starting to looking interesting, in a nice big falling wedge coming into the 200dma with a gap fill just below and supporting volume price profile.
LLY - Monthly Support (19/8/20)Sideway between weekly support and monthly ressistance. Potential breakout?
Rising WedgeLLY has broken bottom trend line of it's latest rising wedge pattern and has dipped a ways since she fell out
There are multiple rising wedges since the flu hit this stock. There is a green volume spike when LLY dipped down to 140ish
Earnings are not until October.
I am watching for now
Eli Lilly and Co+ experts and j.p. morgan predict 180-190 price target
+ technically good entry point with 3:1 r/r ration
- technically in the bubble and overvalued
- ending diagonal pattern with triple divergence, so we can fall much lower
Considering buy with close stops
daily analysis of ELI LILLY AND COMPANY hello my friends
the one hour chart of this market that it will experience a downtrend with the vigilance to take into account the stop loss to be determined on the graph
thank you for subscribing to have more analyzes
Projection on ELI LILLY AND COMPANYHello traders, ELI LILLY AND COMPANY is on a bullish trend line, tenative of sellers aborted on a large volume, preparation to break the compression zone and mounted to seek the highest.
Please LIKE & FOLLOW, thank you!
FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly'LLY: Eli Lilly and Company
2020-06-15 22:21:00
FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly's new rapid-acting insulin
LLY | GAP | Quick Profits | $15 GAP | Very Short Term |LLY will just bearish in the short term, while it fills the gap near $140.
1. Our first confirmation is that the 21 moving average is very far away from the current price at $160. We can see a sharp pull back from the resistance level at $160.
2. The fib retracement has reached 1.161%, which is a massive gain for bulls forcing them to take profits.
3. LLY could fill the gap in the near terms, or come back in the future to give a chance to buyers from $140 - $155 to acquire the stock. If the market doesn't allow the buyers, then is considered somewhat inside trading.
4. Looking at the RSI, we see a straight line up, and we call this a rubber band effect since there are high chances of it snapping back.
I would wait until the end of the market to do your best.
$LLY Oversold - Bullish Hammer on Daily Chart$LLY Oversold - Bullish Hammer on Daily Chart
Pennant formed on shorter time frame charts. Bounce move could be imminent.
Short term target - $148.00
Could quickly see $152.00 if upper down-trend line is broken.
Note: Meant to be educational, not investment advice.
